News
An interaction between two proteins points to a molecular basis for memory. But how do memories last when the molecules that ...
The partners will use UNP's AI-based macrocycle discovery platform to develop synthetic peptide therapeutics for multiple disease targets.
Analytical chemistry researchers at the University of Amsterdam's Van 't Hoff Institute for Molecular Sciences (HIMS) have ...
The mystery deepened in the 1970s when a team of scientists entered the tomb of Polish king Casimir IV. Within weeks, 10 out ...
13d
IFLScience on MSNThe Fungus Blamed For “Tutankhamun’s Curse” Could Make A Potent Anti-Cancer DrugThe fungus Aspergillus flavus produces a class of molecules that have strong potential as future anti-leukemia drugs, ...
NGR peptides that recognize CD13 receptors in tumor neovasculature are of high interest, in particular due to their potential applications in drug targeting. Here we report the synthesis and ...
Penn-led researchers have turned a deadly fungus into a potent cancer-fighting compound. After isolating a new class of ...
Penn-led researchers have turned a deadly fungus into a potent cancer-fighting compound. After isolating a new class of ...
The same deadly fungus is now being looked at as a potential cancer treatment. The therapy detailed in this new study is a ...
The chemokine receptor CXCR7 is an atypical CXCL12 receptor that, as opposed to the classical CXCL12 receptor CXCR4, signals preferentially via the β-arrestin pathway and does not mediate chemotaxis.
Semaglutide, a synthetic analog of glucagon-like peptide-1 (GLP-1), has garnered attention for its intriguing properties and potential implications in various r ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results